Literature DB >> 33672869

Urinary Cell-Free DNA in Bladder Cancer Detection.

Ryan Tsz-Hei Tse1, Hongda Zhao1, Christine Yim-Ping Wong1, Carol Ka-Lo Cheng1, Angel Wing-Yan Kong1, Qiang Peng1, Peter Ka-Fung Chiu1, Chi-Fai Ng1, Jeremy Yuen-Chun Teoh1.   

Abstract

Urinary bladder cancer is a common urological cancer. Although flexible cystoscopy is widely employed in bladder cancer detection, it is expensive, invasive, and uncomfortable to the patients. Recently, urinary cell-free DNA (ucfDNA) isolated from urine supernatant has been shown to have great potential in bladder cancer detection and surveillance. Molecular features, such as integrity and concentration of ucfDNA, have been shown to be useful for differentiating bladder cancer patients from healthy controls. Besides, bladder cancer also exhibits unique genetic features that can be identified from sequencing and expression of ucfDNA. Apart from bladder cancer detection, ucfDNA is also useful for molecular classification. For example, ucfDNA exhibits significant differences, both molecularly and genetically, in non-muscle-invasive and muscle-invasive bladder cancers. There is no doubt that ucfDNA is a very promising tool for future applications in the field of bladder cancer.

Entities:  

Keywords:  biomarker; bladder cancer; detection; non-invasive; urinary cell-free DNA

Year:  2021        PMID: 33672869     DOI: 10.3390/diagnostics11020306

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  2 in total

Review 1.  DNA methylation-based predictors of health: applications and statistical considerations.

Authors:  Paul D Yousefi; Matthew Suderman; Ryan Langdon; Oliver Whitehurst; George Davey Smith; Caroline L Relton
Journal:  Nat Rev Genet       Date:  2022-03-18       Impact factor: 53.242

Review 2.  Urinary Markers for Bladder Cancer Diagnosis and Monitoring.

Authors:  Seung-Hwan Jeong; Ja Hyeon Ku
Journal:  Front Cell Dev Biol       Date:  2022-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.